ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2014 to Q2 2021

Type / Class
Debt / NOTE 1.750% 6/1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2021 Q2 $0 $0 -$64,373,000 0
2021 Q1 $66,335,000 $64,373,000 +$2,460,433 97.5% 9
2020 Q4 $58,705,000 $33,077,000 +$275,043 55.01% 11
2020 Q3 $50,185,000 $42,149,000 85.66% 9
2020 Q2 $53,435,000 $45,984,000 -$14,301 86.51% 11
2020 Q1 $65,950,000 $57,371,000 +$1,631,381 87.04% 15
2019 Q4 $65,950,000 $50,031,000 -$191,275,673 75.17% 15
2019 Q3 $309,989,000 $243,081,000 -$2,745,412 78.54% 31
2019 Q2 $311,049,000 $265,754,000 -$11,103,578 85.14% 33
2019 Q1 $322,427,888 $287,013,000 -$6,324,251 88.63% 31
2018 Q4 $331,259,500 $275,710,276 +$3,758,460 83.24% 37
2018 Q3 $328,201,540 $278,699,000 +$2,600,850 84.9% 41
2018 Q2 $322,286,824 $312,319,379 -$7,471,910 96.85% 43
2018 Q1 $329,642,811 $301,007,000 +$6,235,211 91.39% 41
2017 Q4 $327,177,641 $278,394,000 +$6,971,026 85.18% 40
2017 Q3 $318,597,588 $287,815,000 +$10,034,369 90.3% 41
2017 Q2 $309,106,035 $265,334,000 -$13,035,586 85.82% 40
2017 Q1 $324,511,750 $277,633,000 +$150,053 85.02% 39
2016 Q4 $329,329,000 $250,488,000 -$3,213,253 76.0% 44
2016 Q3 $330,321,000 $269,628,705 -$11,216,966 81.58% 39
2016 Q2 $340,075,000 $297,805,363 -$2,517,301 87.53% 33
2016 Q1 $342,137,000 $304,789,460 -$16,343,801 89.15% 34
2015 Q4 $340,214,000 $391,001,400 +$19,995,250 115.2% 33
2015 Q3 $319,739,991 $290,779,806 -$13,432,424 91.03% 35
2015 Q2 $333,367,212 $335,992,816 -$8,013,400 101.2% 40
2015 Q1 $343,129,000 $350,456,473 +$4,515,969 102.32% 41
2014 Q4 $327,652,163 $376,803,322 +$15,542,312 115.06% 45
2014 Q3 $310,542,902 $321,947,872 +$292,254,041 103.74% 44
2014 Q2 $21,200,000 $21,443,000 +$21,443,000 103.69% 5